4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001209191-22-049212
Options or other derivatives
- Chief Operating Officer acquired 354,532 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Bensen Daniel Chief Operating Officer | 2022-09-06 | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | D: show line 1 in the form | |||||
| Bensen Daniel Chief Operating Officer | 2022-09-06 | Grant or award · Stock Option (Right to Buy) | +249,532 | 249,532 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…